Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Effects of VLCKD in Metabolic Syndrome [NA]
A clinical trial is evaluating the effects of a very low calorie ketogenic diet (VLCKD) on metabolic syndrome and related conditions, includ…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Genetic-specific Effects of Fructose on Liver Lipogenesis [NA]
A completed clinical trial from the University of North Carolina examined how genetic factors influence fructose-induced liver lipogenesis i…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study
Clinical trial NCT05712603, The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study, has completed according to ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease [Phase 3]
Phase 3 trial update noting completion of a study evaluating N-acetylcysteine in patients with non-alcoholic fatty liver disease (simple ste…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic Steatosis [NA]
Completed study assessing liver and metabolic effects of insulin pump therapy in adults with type 2 diabetes and non-alcoholic fatty liver d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Combined Active Treatment in Type 2 Diabetes with NASH [Phase 4]
A Phase 4 clinical trial evaluating a combined active treatment approach for type 2 diabetes mellitus with non-alcoholic steatohepatitis (NA…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease
This completed clinical trial evaluated the cost-effectiveness of physical exercise for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers [Phase 1]
A Phase 1 trial completed to evaluate the effect of food on the pharmacokinetics of ASC41 in healthy volunteers, with study context includin…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD. [Phase 1]
Phase 1 trial update for ASC41, including a drug-drug interaction study in healthy volunteers and pharmacokinetics, safety, and tolerability…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Treating Pediatric NAFLD with Nutrition [NA]
A completed clinical trial from the University of California, San Diego evaluates nutrition-based interventions for pediatric Non-Alcoholic …
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Study in Healthy Adults Evaluating PF-07202954 [Phase 1]
Pfizer completed a Phase 1 study in healthy adults evaluating PF-07202954 for potential application in non-alcoholic fatty liver disease and…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD) [NA]
A completed clinical trial evaluated the effects of aerobic exercise on lean non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Lifestyle Changes in PCOS with OSA and NAFLD [NA]
A Cairo University trial is evaluating lifestyle changes for women with polycystic ovary syndrome who also have obstructive sleep apnea and …
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis [NA]
A completed clinical trial from Children's Hospital Los Angeles examines whether a rebaudioside extract can help occlude excess hepatic stea…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial from China Medical University evaluating a low-free-sugar dietary intervention for children with non-alcoholic fa…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Ultrasound and Attenuation Imaging
Clinical trial update reporting a completed study on ultrasound and attenuation imaging for assessing fatty liver disease, including non-alc…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
A Phase 2 clinical trial is investigating whether soymilk consumption affects liver disease severity in children with non-alcoholic fatty li…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Free Walking Exercise in Obstructive Sleep Apnea Patients With Non-alcoholic Fatty Liver [NA]
A clinical trial is assessing the impact of free walking exercise in adults with obstructive sleep apnea and non-alcoholic fatty liver disea…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Effect of Sodium Glucose Cotransporter Inhibitors Fatty Liver Disease Patients Fatigue Assessment [NA]
A completed clinical trial evaluating whether SGLT inhibitors impact fatigue in patients with non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease [Phase 4]
Phase 4 trial evaluating the efficacy and safety of liraglutide for obesity in the context of non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation [NA]
A completed clinical trial assessing whether a probiotic formulation benefits patients with non-alcoholic fatty liver disease and modulates …
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD) [NA]
A clinical trial update for PARADISE-NAFLD assessing focused power ultrasound–mediated modification of inferior perirenal adipose tissue as …
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men [Phase 1]
Phase 1 pharmacokinetics study assessing a single dose of NNC0194-0499 in Chinese men with non-alcoholic fatty liver disease has been comple…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption [NA]
Completed clinical trial update evaluating the biological activity of serum enriched after TOTUM-448 consumption, in the context of NAFLD an…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study) [Phase 2]
Phase 2 study of semaglutide for non-alcoholic fatty liver disease in HIV infection completed, with results posted in May 2024.